Tudor Investment Corp’s Integra LifeSciences IART Stock Holding History

Tudor Investment Corp’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-79,927	Closed	-$1.76M	–	3469
2025 Q1	$1.76M	Sell	79,927 -128,148	-62%	-$3.01M	0.01%	1437
2024 Q4	$4.72M	Sell	208,075 -63,343	-23%	-$1.38M	0.02%	727
2024 Q3	$4.93M	Sell	271,418 -9,900	-4%	-$229K	0.02%	717
2024 Q2	$8.2M	Buy	281,318 +8,535	+3%	+$253K	0.04%	453
2024 Q1	$9.67M	Buy	272,783 +124,503	+84%	+$4.98M	0.06%	366
2023 Q4	$6.46M	Buy	148,280 +46,860	+46%	+$1.84M	0.05%	518
2023 Q3	$3.87M	Sell	101,420 -103,921	-51%	-$4.37M	0.04%	612
2023 Q2	$8.45M	Buy	205,341 +8,292	+4%	+$399K	0.1%	229
2023 Q1	$11.3M	Buy	197,049 +5,946	+3%	+$335K	0.18%	116
2022 Q4	$10.7M	Buy	191,103 +45,942	+32%	+$2.34M	0.21%	70
2022 Q3	$6.15M	Buy	145,161 +30,499	+27%	+$1.56M	0.13%	169
2022 Q2	$6.2M	Buy	114,662 +38,368	+50%	+$2.3M	0.16%	128
2022 Q1	$4.9M	Buy	76,294 +62,090	+437%	+$4.09M	0.11%	225
2021 Q4	$952K	Buy	14,204 +3,929	+38%	+$266K	0.02%	1034
2021 Q3	$704K	Sell	10,275 -39,570	-79%	-$2.8M	0.01%	1415
2021 Q2	$3.4M	Buy	+49,845	New	+$3.52M	0.06%	365
2021 Q1	–	Sell	-21,696	Closed	-$1.41M	–	1700
2020 Q4	$1.41M	Buy	+21,696	New	+$1.17M	0.04%	559
2020 Q3	–	Sell	-22,513	Closed	-$1.06M	–	1408
2020 Q2	$1.06M	Buy	22,513 +9,180	+69%	+$451K	0.05%	451
2020 Q1	$596K	Buy	13,333 +7,924	+146%	+$416K	0.05%	423
2019 Q4	$315K	Buy	+5,409	New	+$322K	0.01%	857
2019 Q2	–	Sell	-4,520	Closed	-$252K	–	1203
2019 Q1	$252K	Sell	4,520 -7,207	-61%	-$367K	0.01%	919
2018 Q4	$529K	Buy	+11,727	New	+$643K	0.01%	574
2018 Q3	–	Sell	-21,257	Closed	-$1.37M	–	1160
2018 Q2	$1.37M	Buy	+21,257	New	+$1.32M	0.05%	336
2017 Q2	–	Sell	-14,629	Closed	-$616K	–	1182
2017 Q1	$616K	Buy	+14,629	New	+$625K	0.02%	577
2016 Q4	–	Sell	-16,010	Closed	-$661K	–	1498
2016 Q3	$661K	Buy	+16,010	New	+$671K	0.02%	591
2016 Q2	–	Sell	-6,884	Closed	-$232K	–	1758
2016 Q1	$232K	Buy	+6,884	New	+$214K	0.01%	1435
2015 Q4	–	Sell	-105,620	Closed	-$3.15M	–	1734
2015 Q3	$3.15M	Sell	105,620 -404,885	-79%	-$12.7M	0.11%	136
2015 Q2	$14.1M	Buy	510,505 +21,211	+4%	+$565K	0.41%	43
2015 Q1	$12.3M	Buy	489,294 +466,393	+2,037%	+$11M	0.39%	37
2014 Q4	$508K	Buy	22,901 +4,063	+22%	+$82.4K	0.02%	718
2014 Q3	$382K	Buy	18,838 +4,159	+28%	+$82.8K	0.01%	846
2014 Q2	$282K	Sell	14,679 -4,159	-22%	-$77.5K	0.01%	873
2014 Q1	$354K	Sell	18,838 -11,254	-37%	-$217K	0.02%	706
2013 Q4	$587K	Buy	30,092 +5,383	+22%	+$98.7K	0.03%	454
2013 Q3	$407K	Sell	24,709 -5,138	-17%	-$82.4K	0.02%	439
2013 Q2	$447K	Buy	+29,847	New	+$437K	0.03%	380

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tudor Investment Corp's IART Position: Q2 2025 in Review

Tudor Investment Corp sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 79,927 shares — an estimated $1.76M sold.

Tudor Investment Corp first reported a position in IART in Q2 2013 and held it in 36 quarters. The position peaked at $14.1M in Q2 2015. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Tudor Investment Corp reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Tudor Investment Corp sold 79,927 Integra LifeSciences shares in Q2 2025, an estimated $1.76M.
Tudor Investment Corp first reported a position in Integra LifeSciences in Q2 2013 and held it in 36 quarters.
Tudor Investment Corp's Integra LifeSciences position peaked at $14.1M in Q2 2015.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.